Enzyme Regulates Protein Synthesis and Gene Expression (G127253)

Target Name: TYW3

NCBI ID: G127253

TYW3

Enzyme Regulates Protein Synthesis and Gene Expression

TYW3, or tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase, is a enzyme that plays a crucial role in the regulation of protein synthesis in the cell. The tRNA(Phe) molecule is a central player in the process of translation of mRNA into functional proteins. The 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme modifies the tRNA(Phe) molecule, specifically the 3'-end of the molecule.

The 3'-end of the tRNA(Phe) molecule is a critical region that plays a crucial role in the stability and stability of the translation complex. The 3'-end of the tRNA(Phe) molecule is modified by the 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme, which adds a methyl group to the 3'-end of the tRNA(Phe) molecule. This modification is critical for the stability of the translation complex, as the tRNA(Phe) molecule is involved in the formation of the translation complex.

The 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme is also involved in the regulation of gene expression. The enzyme modifies the tRNA(Phe) molecule, which carries the genetic information from the DNA to the ribosome. The modification of the tRNA(Phe) molecule by the 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme can affect the translation of specific genes into the protein.

The 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. The enzyme has been shown to be involved in the regulation of the translation of specific genes involved in cell growth and apoptosis, as well as the regulation of the immune response.

In addition to its role in gene regulation, the 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme is also a potential drug target. The drug target is the tRNA(Phe) molecule, which is modified by the 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme. The drug target is involved in the regulation of protein synthesis, gene expression, and cellular processes such as cell growth, apoptosis, and inflammation.

The 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme is a promising drug target for the treatment of various diseases. For example, the 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme has been shown to be involved in the regulation of the development and progression of certain types of cancer, such as lung cancer and colon cancer.

In conclusion, the 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase enzyme is a critical regulator of protein synthesis and gene expression in the cell. The enzyme plays a crucial role in the formation of the translation complex and the regulation of cellular processes such as cell growth, apoptosis, and inflammation. The drug target of the 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-

Protein Name: TRNA-yW Synthesizing Protein 3 Homolog

Functions: Probable S-adenosyl-L-methionine-dependent methyltransferase that acts as a component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3'-position adjacent to the anticodon of eukaryotic phenylalanine tRNA (By similarity)

The "TYW3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TYW3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets